Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Total Centella Glycosides is a standardized natural botanical extract derived from the whole plant of *Centella asiatica* (L.) Urban, developed by Guangxi Changzhou Natural Pharmaceutical. The extract is primarily composed of pentacyclic triterpene glycosides, including asiaticoside, madecassoside, asiatic acid, and madecassic acid. It is utilized as a pharmaceutical raw material and botanical ingredient in the formulation of dermatological treatments for wound healing, psoriasis, and eczema, as well as in cosmetic and dietary supplement products. The extract exhibits anti-inflammatory, antioxidant, and wound-healing properties, and has been traditionally used for memory improvement and anxiolytic effects. It is available in various concentrations and water-soluble versions and is recognized in the Chinese Pharmacopoeia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Total Centella Glycosides.